Reduced sodium current in GABAergic interneurons in a mouse model of severe myoclonic epilepsy in infancy

被引:817
|
作者
Yu, Frank H.
Mantegazza, Massimo
Westenbroek, Ruth E.
Robbins, Carol A.
Kalume, Franck
Burton, Kimberly A.
Spain, William J.
McKnight, G. Stanley
Scheuer, Todd
Catterall, William A. [1 ]
机构
[1] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA
[2] Univ Washington, Dept Neurol Surg, Seattle, WA 98195 USA
[3] Univ Washington, Dept Neurol, Seattle, WA 98195 USA
[4] Inst Neurol Besta, Dept Neurophysiol, I-20126 Milan, Italy
基金
加拿大健康研究院;
关键词
D O I
10.1038/nn1754
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Voltage-gated sodium channels (Na-V) are critical for initiation of action potentials. Heterozygous loss-of-function mutations in Na(V)1.1 channels cause severe myoclonic epilepsy in infancy (SMEI). Homozygous null Scn1a(-/-) mice developed ataxia and died on postnatal day (P) 15 but could be sustained to P17.5 with manual feeding. Heterozygous Scn1a(+/-) mice had spontaneous seizures and sporadic deaths beginning after P21, with a notable dependence on genetic background. Loss of Na(V)1.1 did not change voltage-dependent activation or inactivation of sodium channels in hippocampal neurons. The sodium current density was, however, substantially reduced in inhibitory interneurons of Scn1a(+/-) and Scn1a(-/-) mice but not in their excitatory pyramidal neurons. An immunocytochemical survey also showed a specific upregulation of Na(V)1.3 channels in a subset of hippocampal interneurons. Our results indicate that reduced sodium currents in GABAergic inhibitory interneurons in Scn1a(+/-) heterozygotes may cause the hyperexcitability that leads to epilepsy in patients with SMEI.
引用
收藏
页码:1142 / 1149
页数:8
相关论文
共 50 条
  • [21] DRAVET SYNDROME (SEVERE MYOCLONIC EPILEPSY OF INFANCY)
    Pahlavan, G.
    DRUGS OF THE FUTURE, 2009, 34 (01) : 61 - 65
  • [22] Genetic predisposition to severe myoclonic epilepsy in infancy
    Benlounis, A
    Nabbout, R
    Feingold, J
    Parmeggiani, A
    Guerrini, R
    Kaminska, A
    Dulac, O
    EPILEPSIA, 2001, 42 (02) : 204 - 209
  • [23] Sodium channel α-1 subunit mutations in severe myoclonic epilepsy of infancy and infantile spasms
    Mulley, J
    Wallace, R
    Hodgson, B
    Grinton, B
    Gardiner, R
    Robinson, R
    Rodriguez-Casero, V
    Sadlier, L
    Morgan, J
    Harkin, L
    Dibbens, L
    Yamamoto, T
    Andermann, E
    Berkovic, S
    Scheffer, I
    AMERICAN JOURNAL OF HUMAN GENETICS, 2003, 73 (05) : 579 - 579
  • [24] Early intervention for a child with severe myoclonic epilepsy of infancy
    Fernández, JC
    Buceta, MJ
    Torres, MC
    BRITISH JOURNAL OF DEVELOPMENTAL DISABILITIES, 2001, 47 (92): : 15 - 20
  • [25] Prognosis of severe myoclonic epilepsy in infancy (Dravet syndrome)
    Chiron, C
    PROGNOSIS OF EPILEPSIES, 2003, : 239 - 248
  • [26] Stiripentol In Severe Myoclonic Epilepsy of Infancy (Dravet Syndrome)
    Plosker, Greg L.
    CNS DRUGS, 2012, 26 (11) : 993 - 1001
  • [27] Understanding and treating a channelopathy - Severe myoclonic epilepsy of infancy
    Krauss, Gregory L.
    Morrison, Peter F.
    NEUROLOGY, 2007, 69 (03) : 233 - 234
  • [28] StiripentolIn Severe Myoclonic Epilepsy of Infancy (Dravet Syndrome)
    Greg L. Plosker
    CNS Drugs, 2012, 26 : 993 - 1001
  • [29] Immunological study in patient with severe myoclonic epilepsy in infancy
    Nieto, M
    Roldán, S
    Sánchez, B
    Candau, R
    Rodríguez, R
    REVISTA DE NEUROLOGIA, 2000, 30 (05) : 412 - 414
  • [30] 4 CASES OF SEVERE MYOCLONIC EPILEPSY IN INFANCY (SMEI)
    HIBIO, S
    KUSUME, Y
    INUI, A
    OHHARA, Y
    ARIIZUMI, M
    BRAIN & DEVELOPMENT, 1988, 10 (04): : 265 - 266